Medicinal Research Reviews

Papers
(The median citation count of Medicinal Research Reviews is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
244
216
In Memoriam: Professor Minyong Li (1976–2025)197
Decoding Gene Expression Changes in Cerebral Tumors: Before and After Radiotherapy174
Key characters of glycodrugs153
Design, synthesis, and applications of ring‐functionalized histidines in peptide‐based medicinal chemistry and drug discovery123
New drug approvals for 2022: Synthesis and clinical applications118
Accelerating Small Molecule Ferroptosis Regulator Development With Advances in Biological Functions113
Nanotechnology‐based electrochemical biosensors for monitoring breast cancer biomarkers96
Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment96
Multi‐Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns92
Galectin‐8 inhibition and functions in immune response and tumor biology91
The role and prospect of lysine‐specific demethylases in cancer chemoresistance90
Hydroxamic Acids as HDAC Inhibitor Drug Leads for Malaria85
Indirect influence on the BDNF/TrkB receptor signaling pathway via GPCRs, an emerging strategy in the treatment of neurodegenerative disorders84
83
Front Cover Image, Volume 45, Issue 183
Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel77
Current and emerging approaches to noncompetitive AR inhibition77
Targeting Histone H3K9 Methyltransferase G9a as a Potential Therapeutic Strategy for Neuropsychiatric Disorders65
Issue Information65
Rethinking therapeutic strategies of dual‐target drugs: An update on pharmacological small‐molecule compounds in cancer65
Metal complexes bearing EGFR‐inhibiting ligands as promising anticancer agents50
A Focus on Natural Autophagy Modulators as Potential Host‐Directed Weapons Against Emerging and Re‐Emerging Viruses47
Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases44
Mechanism and application of β‐adrenoceptor blockers in soft tissue wound healing43
The ethnomedicinal and functional uses, phytochemical and pharmacology of compounds from Ardisia species: An updated review43
Smart Integration of Structural Biology and Medicinal Chemistry to Unlock Target‐Driven Drug Discovery43
An overview of sphingosine‐1‐phosphate receptor 2: Structure, biological function, and small‐molecule modulators40
Mitochondrial quality control proteases and their modulation for cancer therapy40
Current nanocomposite advances for biomedical and environmental application diversity40
α‐Synuclein in Parkinson's Disease: From Bench to Bedside40
Emerging roles of nerve‐bone axis in modulating skeletal system39
A Possibility of Synthetic Lethality: Wee1 Kinase as a Promising Treating Target for Cancer37
Targeting lysosomal quality control as a therapeutic strategy against aging and diseases37
Enhancing healthy aging with small molecules: A mitochondrial perspective37
Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis36
Issue Information36
Human Cyclophilins—An Emerging Class of Drug Targets35
Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds35
An overview of the progress made in research into the Mpox virus34
Arginine Competition in Tumor Microenvironment: A Potential Target for Cancer Therapy34
Inside Front Cover Image, Volume 44, Issue 534
Designing the Next Generation of Antibiotics: Structure, SAR, and Strategy in Medicinal Chemistry (2000–2025)34
Targeting epigenetic modifications in Parkinson's disease therapy33
Small molecules targeting different cellular pathologies for the treatment of amyotrophic lateral sclerosis33
Targeted immunotherapy and nanomedicine for rhabdomyosarcoma: The way of the future33
Advances in reversible covalent kinase inhibitors32
LSD1 in drug discovery: From biological function to clinical application32
HMGB1: From Molecular Functions to Clinical Applications in Cancer and Inflammatory Diseases31
Innovative pathological network‐based multitarget approaches for Alzheimer's disease treatment31
ER stress and inflammation crosstalk in obesity30
Glutathione‐triggered prodrugs: Design strategies, potential applications, and perspectives29
Issue Information29
Translating mesenchymal stem cell and their exosome research into GMP compliant advanced therapy products: Promises, problems and prospects29
29
CXCR4/CXCL12 axis: “old” pathway as “novel” target for anti‐inflammatory drug discovery29
The Contribution of Cholesterol and Squalene Synthase in Cancer: Molecular Mechanisms, Lipid Rafts and Therapeutic Approaches28
28
28
Mutations of TRPM8 channels: Unraveling the molecular basis of activation by cold and ligands27
The application of zebrafish patient‐derived xenograft tumor models in the development of antitumor agents27
Compelling Evidence: A Critical Update on the Therapeutic Potential of Carbon Monoxide26
Kinin B 1 and B 2 Receptors: Role in Tumor Progression and Pain Associated With Tumor and Anticanc26
Computational benchmarking of putative KIFC1 inhibitors25
Astatine‐211—Towards In Vivo Stable Astatine‐211 Labeled Radiopharmaceuticals and Their (Pre)Clinical Applications25
Quantification of 10 B and 11 B in Biological Samples in Translational Science and Clinical Applic25
Chemistry and biological activity of resin glycosides from Convolvulaceae species24
OGG1: An emerging multifunctional therapeutic target for the treatment of diseases caused by oxidative DNA damage23
23
A comprehensive and systemic review of ginseng‐based nanomaterials: Synthesis, targeted delivery, and biomedical applications23
A comprehensive review on the development of chiral Cu, Ni, and Zn complexes as pharmaceutical agents over the past decades: Synthesis, molecular structure and biological activity23
Harnessing the Power of Natural Products for Targeted Protein Degradation23
23
Issue Information23
Front Cover Image, Volume 45, Issue 423
KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential22
Canonical effects of cytokines on glomerulonephritis: A new outlook in nephrology22
Research progress in spike mutations of SARS‐CoV‐2 variants and vaccine development22
Targeting ClpP Protease: Emerging Therapeutic Strategies and Small‐Molecule Modulators in Drug Discovery22
Medicinal Chemistry Strategies for the Development of CD73 Inhibitors in Cancer Immunotherapy22
H+‐slip correlated to rotor free‐wheeling as cause of F1FO‐ATPase dysfunction in primary mitochondrial disorders21
Tirzepatide in Metabolic Diseases: Clinical Efficacy and Safety Beyond Diabetes and Obesity21
Natural products as IL‐6 inhibitors for inflammatory diseases: Synthetic and SAR perspective21
20
20
20
Issue Information20
Advances in machine intelligence‐driven virtual screening approaches for big‐data19
Poly (adenosine diphosphate‐ribose) polymerase inhibitors in the treatment of triple‐negative breast cancer with homologous repair deficiency19
Recent Developments in the Optical Control of Adrenergic Signaling19
Advances in SIRT2‐Targeted Therapeutics: Structural Insights, Chemical Strategies, and Degrader Technologies19
Comprehensive Insights Into Sulfanilamido‐Based Medicinal Design and Research19
Comparison of Radionuclide Drug Conjugates With Boron Neutron Capture Therapy: An Overview of Targeted Charged Particle Radiation Therapy19
19
Experimental structure based drug design (SBDD) applications for anti‐leishmanial drugs: A paradigm shift?18
Synthesis and Clinical Application of Small‐Molecule Drugs Approved by FDA in 202518
Issue Information18
Cuproptosis: Mechanism, role, and advances in urological malignancies18
Covalent Bifunctional Molecules (CBMs): Achievements and Challenges18
Revisiting Aurora Kinase B: A promising therapeutic target for cancer therapy18
Mucin O‐Glycosylation and Mucolytic Therapies in Pseudomyxoma Peritonei: Literature Review18
Biofabrication approaches and regulatory framework of metastatic tumor‐on‐a‐chip models for precision oncology17
17
Recent Advances of Non‐Nucleoside Polymerase Inhibitors With Broad‐Spectrum Antiviral Activities16
Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands16
Near‐Infrared Fluorescent Probe for the Early Diagnosis of Alzheimer's Disease16
Cutting‐Edge Therapy and Immune Escape Mechanisms in EBV‐Associated Tumors16
Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies16
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders16
Unleashing the Power of Covalent Drugs for Protein Degradation16
Insights From Spatiality: Accelerating Pharmaceutical Research Using Mass Spectrometry Imaging15
Profiling of small‐molecule necroptosis inhibitors based on the subpockets of kinase–ligand interactions15
Transient receptor potential vanilloid 1 (TRPV1)‐independent actions of capsaicin on cellular excitability and ion transport15
Extracellular vesicles: Emerging frontiers in wound healing15
1,2,4,5‐Tetraoxane derivatives/hybrids as potent antimalarial endoperoxides: Chronological advancements, structure−activity relationship (SAR) studies and future perspectives15
The menace of severe adverse events and deaths associated with viral gene therapy and its potential solution15
Issue Information14
Chemo‐proteomics in antimalarial target identification and engagement14
Issue Information14
Front Cover Image, Volume 44, Issue 514
The role of Toll‐like receptors in neuropsychiatric disorders: Immunopathology, treatment, and management14
14
The role of flavonoids in the regulation of epithelial‐mesenchymal transition in cancer: A review on targeting signaling pathways and metastasis14
Issue Information13
Artemisinins: Promising drug candidates for the treatment of autoimmune diseases13
Issue Information13
Issue Information13
Recent Progress in Azobenzene‐Based In Vivo Photopharmacology13
Molecular mechanisms and therapeutic perspectives of peroxisome proliferator‐activated receptor α agonists in cardiovascular health and disease12
Urologic Bacteriome: The Hero or the Villain in Prostate Cancer Onset, Progression, and Treatment?12
Development and therapeutic potential of GSPT1 molecular glue degraders: A medicinal chemistry perspective12
Unrevealing the connection between real sample analysis and analytical method. The case of cytokines12
Pyroptosis and the fight against lung cancer12
The antisickling agent, 5‐hydroxymethyl‐2‐furfural: Other potential pharmacological applications11
Issue Information11
The Current Progress in the Quest for Vaccines Against the Semliki Forest Virus Complex11
Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseases11
Issue Information11
Therapeutic Potential of Vascular Adhesion Protein‐1 (VAP‐1)/Semicarbazide‐Sensitive Amine Oxidase (SSAO) Inhibitors: Current Medicinal Chemistry and Emerging Opportunities11
How Artificial Intelligence Assists in Overcoming Drug Resistance?10
Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin10
The recent advance and prospect of poly(ADP‐ribose) polymerase inhibitors for the treatment of cancer10
Parkin exerts the tumor‐suppressive effect through targeting mitochondria10
Bacterial proton motive force as an unprecedented target to control antimicrobial resistance10
Issue Information10
The triangular relationship between traditional Chinese medicines, intestinal flora, and colorectal cancer10
Advanced models for respiratory disease and drug studies9
Progress in RAS‐targeted therapeutic strategies: From small molecule inhibitors to proteolysis targeting chimeras9
Beyond dopamine: Novel strategies for schizophrenia treatment9
Immunosuppressive Tumor Microenvironment and Therapeutic Landscape of Diffuse Intrinsic Pontine Glioma9
Revolutionizing the battle against locally advanced breast cancer: A comprehensive insight into neoadjuvant radiotherapy9
Progress and perspective on hydrogen sulfide donors and their biomedical applications9
Front Cover Image, Volume 43, Issue 68
Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management8
Activation and inhibition of sirtuins: From bench to bedside8
Limonoids from neem (Azadirachta indica A. Juss.) are potential anticancer drug candidates8
8
2.7107439041138